S555 The Role of Omega Fatty Acids and Colorectal Cancer Risk—A Systematic Review

Introduction: Colorectal cancer (CRC) is the third leading cause of cancer deaths in the United States. There has been literature suggesting that omega polyunsaturated fatty acids (PUFA) might be protective against colorectal cancer by promoting cell death and reducing inflammation via downregulating the inflammatory cascade through inhibition of prostaglandin-endoperoxide synthase 2. Laboratory research shows benefit whereas observational studies in humans show no overall association. Methods: PRISMA guidelines were followed. MeSH terms including (omega fatty acids or omega-polyunsaturated fatty acids) AND (colorectal cancer or colorectal carcinoma) were used. Cochrane, PubMed, and Google Scholar were used as search engines. Nineteen studies resulted, two were duplicates, six were case reports, and four were literature reviews, leaving seven studies for review, which includes randomized control trials and prospective cohort studies. Results: Alliance trial showed patients with high intake of marine Omega-3 PUFAs and dark fish after colon cancer diagnosis may have longer disease-free survival (DFS). Further a subgroup analysis of this trial showed improved 3-year DFS for wild KRAS mutation but P < 0.05 proved it to be insignificant. Non-KAS tumors, however, showed a hazard ratio of 1.3 with a P = 0.02, indicating an inverse correlation. Higher consumption was associated with better 3-year DFS for tumors with deficient MMR (72% vs 67%) but not proficient MMR (72% vs 72%). The other trial utilizing VITAL cohort showed decrease in CRC risk with PUFA supplementation in men but no association in women. The prospective cohort study revealed no association between fish, omega-3 or omega-6 PUFA intake and CRC risk. Results suggest that associations between PUFA intake and CRC may vary by gender, subsite, and genetic risk. Conclusion: Omega fatty acids have variable mechanisms of action to explain pro and anti-apoptotic effects. Based on the available data, there is no significant association between omega fatty acid supplementation and colorectal cancer risk. Further studies are required to look for the incidence of colorectal cancer and its association with omega fatty acid supplementation.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001129680.80278.43
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S555 The Role of Omega Fatty Acids and Colorectal Cancer Risk—A Systematic Review

Manesh Kumar, Jahnavi Ethakota, Bipneet Singh, Danesh Kumar et al.
The American Journal of Gastroenterology
Cancer, Lipids, and Metabolism
article

S555 The Role of Omega Fatty Acids and Colorectal Cancer Risk—A Systematic Review

Manesh Kumar, Jahnavi Ethakota, Bipneet Singh, Danesh Kumar, FNU Farzeela
article en

Abstract

Introduction: Colorectal cancer (CRC) is the third leading cause of cancer deaths in the United States. There has been literature suggesting that omega polyunsaturated fatty acids (PUFA) might be protective against colorectal cancer by promoting cell death and reducing inflammation via downregulating the inflammatory cascade through inhibition of prostaglandin-endoperoxide synthase 2. Laboratory research shows benefit whereas observational studies in humans show no overall association. Methods: PRISMA guidelines were followed. MeSH terms including (omega fatty acids or omega-polyunsaturated fatty acids) AND (colorectal cancer or colorectal carcinoma) were used. Cochrane, PubMed, and Google Scholar were used as search engines. Nineteen studies resulted, two were duplicates, six were case reports, and four were literature reviews, leaving seven studies for review, which includes randomized control trials and prospective cohort studies. Results: Alliance trial showed patients with high intake of marine Omega-3 PUFAs and dark fish after colon cancer diagnosis may have longer disease-free survival (DFS). Further a subgroup analysis of this trial showed improved 3-year DFS for wild KRAS mutation but P < 0.05 proved it to be insignificant. Non-KAS tumors, however, showed a hazard ratio of 1.3 with a P = 0.02, indicating an inverse correlation. Higher consumption was associated with better 3-year DFS for tumors with deficient MMR (72% vs 67%) but not proficient MMR (72% vs 72%). The other trial utilizing VITAL cohort showed decrease in CRC risk with PUFA supplementation in men but no association in women. The prospective cohort study revealed no association between fish, omega-3 or omega-6 PUFA intake and CRC risk. Results suggest that associations between PUFA intake and CRC may vary by gender, subsite, and genetic risk. Conclusion: Omega fatty acids have variable mechanisms of action to explain pro and anti-apoptotic effects. Based on the available data, there is no significant association between omega fatty acid supplementation and colorectal cancer risk. Further studies are required to look for the incidence of colorectal cancer and its association with omega fatty acid supplementation.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 62%
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.